Abstract
Overview
Introduction
The pediatric and adolescent vaccines market encompasses many different
classes. DTP and MMR combinations continue to form the mainstay of childhood
immunization; however, their growth potential is limited. The key
opportunities lie in novel, innovative additions to established schedules,
particularly pneumococcal (Prevnar), conjugated meningococcal (Menactra) and
HPV (Gardasil) vaccines.
Scope
- Strategic analysis of the pediatric and adolescent vaccines market across
the seven major markets and of key companies in the sector
- Thorough assessment of underlying commercial and clinical influencers
shaping the pediatric and adolescent vaccines market
- Patient-based forecasts for key vaccine classes and products according to
recommended vaccination groups and coverage rates in the seven major markets
- In-depth discussion of novel vaccine pipeline candidates and discussion of
their future potential
Highlights
Driven by the launch of novel, high-price vaccines such as Gardasil or
RotaTeq, the pediatric and adolescent vaccines market is experiencing a rapid
growth. Wyeth' s Prevnar has emerged as the first blockbuster vaccine,
demonstrating that innovative vaccines can command high prices and yield high
revenues in the pediatric vaccines market.
The main future opportunities lie in the pneumococcal, meningococcal and HPV
vaccine sectors, where there is a large medical need. Particularly a vaccine
against infections with N. meningitidis B would have a potentially huge
commercial.
Key challenges include the reluctance of healthcare providers to pay for
increasingly expensive vaccines and the lack of widespread organized
vaccination programs for school children and teenagers. With an increasing
focus on adolescent vaccines such as Gardasil or Menactra, better ways to
reach adolescents for vaccination will have to be found.
Reasons to Purchase
- Review clinical and commercial factors driving new product decisions and
the strategies of key players in the pediatric and adolescent vaccines market
- Gain insight through a patient-based forecast and a thorough analysis of
marketed and pipeline products as well as case studies in key vaccine classes
- Understand concerns, unmet needs and future opportunities by learning
about the views of key pediatric and adolescent vaccine opinion leaders
| 
View Cart
